Total Funding
71
23
Total FundingSeed raised
Growth Score 71 in past quarter
-5 pts
Heat Score 23 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
664307
Proteonomix develops therapies using human stem cells and their derivatives to treat diabetes and cardiac diseases.
- Michael Cohen: Founder, Director, and CEO
- Ian McNiece: Chief Scientific Officer
About the Company
Our Technologies were developed over years of research and development at leading US medical universities. Several technologies are entering the commercialization phase and others are ready to proceed through the FDA phased human trials process.
